Stockreport

Leap Therapeutics Presents Positive DKN-01 Clinical Data in Biliary Tract Cancers at American Society of Clinical Oncology (ASCO) 2017 Annual Meeting

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com
PDF CAMBRIDGE, Mass., May 17, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, [Read more]